多基因途径塑造了白质对阿尔茨海默病相关病理生理变化的脆弱性
Mario Tranfa1,2, Leonard Pieperhoff3,4, Giuseppe Pontillo3,5,6,7
1Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUmc Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, Netherlands. m.tranfa@amsterdamumc.nl.
遗传风险路径影响阿尔茨海默病 (AD) 的大脑变化. 特定的途径改变了粉样β (Aβ) 和化Tau (p-Tau) 对白质完整性的影响,为干预提供了目标.
科学领域:
- 神经科学与遗传学
- 阿尔茨海默氏症疾病研究研究
- 大脑成像和结构分析
背景情况:
- 阿尔茨海默氏病 (AD) 在生物学上是由粉样β (Aβ) 和酸化Tau (p-Tau) 积累而定义的,但症状发作有显著的差异.
- 遗传因素及其与蛋白质病变的相互作用可能解释认知完整个体中AD进展的异质性.
- 了解这些对大脑结构的遗传影响对于早期检测和干预策略至关重要.
研究的目的:
- 研究AD相关的病理生理变化 (Aβ1-42,p-Tau181),多基因风险得分 (PRS) 和认知完整的老年人白质 (WM) 结构之间的关联.
- 检查特定途径的PRS如何与Aβ1-42和p-Tau181相互作用,以影响WM的微观和宏观结构性质.
- 确定有助于AD风险和影响大脑完整性的特定遗传途径.
主要方法:
- 利用了来自欧洲预防阿尔茨海默氏症痴呆症 (EPAD) 队列的803名认知完整个体的数据,以及可用的CSF生物标志物,基因型和MRI数据.
- 从85个与AD相关的遗传变异中计算了六个功能集群 (免疫激活,信号转导,炎症,脂质,粉样蛋白,清除) 的特定途径PRS.
- 使用基于fixel的扩散MRI分析来评估WM通道中的纤维密度 (FD) 和纤维截面 (FC),分析与PRS和生物标志物水平的相互作用.
主要成果:
- 化Tau181 (p-Tau181) 与纤维密度 (FD) 的增加有关,而脂质通路PRS与更大的FD和纤维截面 (FC) 相相关.
- 清除途径PRS调节了粉样β1-42 (Aβ1-42) 对FD的影响,在Aβ阳性个体中显示出积极的关联.
- 免疫激活途径PRS调节了p-Tau181对FD的影响,在p-Tau阳性个体中观察到负相关性.
结论:
- 路径特定的AD遗传脆弱性与WM改变直接相关,并调节AD生物标志物的影响.
- 将AD相关的遗传风险纳入诊断框架,可以促进针对临床前AD的查和干预.
- 这些发现强调了考虑遗传途径在理解AD异质性和开发个性化治疗策略方面的重要性.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
相关概念视频
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
